Stavros G. Vizirgianakis - 11 Jun 2026 Form 4 Insider Report for Apyx Medical Corp (APYX)

Reporting relationship: Director
Issuer ticker: APYX
Reported as of: 11 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Jun 2026, 19:00:10 UTC
Prior SEC filing: 18 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Stavros G. Vizirgianakis

Key filing fact

Stavros G. Vizirgianakis filed Form 4 for Apyx Medical Corp (APYX) on 15 Jun 2026.

Key facts

This page summarizes Stavros G. Vizirgianakis's Form 4 filing for Apyx Medical Corp (APYX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Jun 2026, 19:00.

Change

Previous filing in this sequence was filed on 18 Nov 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001559834 Primary reporting owner

Vizirgianakis Stavros G.

Relationship: Director
Address: C/O APYX MEDICAL CORPORATION, 5115 ULMERTON ROAD, CLEARWATER
Signature: /s/ Stavros G. Vizirgianakis
Signature date: 15 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

APYX transaction

Restricted Stock Units

Award

Transaction value
Shares: +450,000
Change %: +26%
Price: $0.000000^*
Shares after: 2,196,191
Date: 11 Jun 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The restricted stock units vest as follows: (i) 150,000 restricted stock units vest immediately on June 11, 2026 (the "Grant Date"); (ii) 150,000 restricted stock units will commence vesting on the first anniversary of the Grant Date and will vest ratably over the twelve (12) month period beginning on such date; and (iii) 150,000 restricted stock units will commence vesting on the second anniversary of the Grant Date and will vest ratably over the twelve (12) month period beginning on such date, in each case subject to the Reporting Person's continued service through each applicable vesting date and the terms and conditions of the applicable award agreement.